Panitch HS - Search Results

1

Increased cathepsin B activity in peripheral blood mononuclear cells of multiple sclerosis patients.

Bever CT Jr, Panitch HS, Johnson KP. Bever CT Jr, et al. Among authors: panitch hs. Neurology. 1994 Apr;44(4):745-8. doi: 10.1212/wnl.44.4.745. Neurology. 1994. PMID: 8164836

2

Glatiramer acetate blocks the activation of THP-1 cells by interferon-gamma.

Li Q, Milo R, Panitch H, Swoveland P, Bever CT Jr. Li Q, et al. Eur J Pharmacol. 1998 Jan 26;342(2-3):303-10. doi: 10.1016/s0014-2999(97)01509-4. Eur J Pharmacol. 1998. PMID: 9548401

3

Gamma-interferon induction in patients with chronic progressive MS.

Bever CT Jr, Panitch HS, Levy HB, McFarlin DE, Johnson KP. Bever CT Jr, et al. Among authors: panitch hs. Neurology. 1991 Jul;41(7):1124-7. doi: 10.1212/wnl.41.7.1124. Neurology. 1991. PMID: 1829795

4

Preliminary trial of 3,4-diaminopyridine in patients with multiple sclerosis.

Bever CT Jr, Leslie J, Camenga DL, Panitch HS, Johnson KP. Bever CT Jr, et al. Among authors: panitch hs. Ann Neurol. 1990 Apr;27(4):421-7. doi: 10.1002/ana.410270411. Ann Neurol. 1990. PMID: 2353797

5

Effects of experimental recombinant interferons on multiple sclerosis.

Johnson KP, Panitch HS. Johnson KP, et al. Among authors: panitch hs. Trans Am Clin Climatol Assoc. 1989;100:171-6. Trans Am Clin Climatol Assoc. 1989. PMID: 2479162 Free PMC article. Review. No abstract available.

6

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system.

Panitch HS, Hirsch RL, Schindler J, Johnson KP. Panitch HS, et al. Neurology. 1987 Jul;37(7):1097-102. doi: 10.1212/wnl.37.7.1097. Neurology. 1987. PMID: 3110648

7

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group.

Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, Myers LW, Panitch HS, Rose JW, Schiffer RB. Johnson KP, et al. Among authors: panitch hs. Neurology. 1995 Jul;45(7):1268-76. doi: 10.1212/wnl.45.7.1268. Neurology. 1995. PMID: 7617181 Clinical Trial.

8

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.

Bever CT Jr, Young D, Anderson PA, Krumholz A, Conway K, Leslie J, Eddington N, Plaisance KI, Panitch HS, Dhib-Jalbut S, et al. Bever CT Jr, et al. Among authors: panitch hs. Neurology. 1994 Jun;44(6):1054-9. doi: 10.1212/wnl.44.6.1054. Neurology. 1994. PMID: 8208399 Clinical Trial.

9

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration.

Khan OA, Xia Q, Bever CT Jr, Johnson KP, Panitch HS, Dhib-Jalbut SS. Khan OA, et al. Among authors: panitch hs. Neurology. 1996 Jun;46(6):1639-43. doi: 10.1212/wnl.46.6.1639. Neurology. 1996. PMID: 8649563 Clinical Trial.

10

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial.

Bever CT Jr, Anderson PA, Leslie J, Panitch HS, Dhib-Jalbut S, Khan OA, Milo R, Hebel JR, Conway KL, Katz E, Johnson KP. Bever CT Jr, et al. Among authors: panitch hs. Neurology. 1996 Dec;47(6):1457-62. doi: 10.1212/wnl.47.6.1457. Neurology. 1996. PMID: 8960727 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters